McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC
McKesson (NYSE: MCK) has completed its acquisition of a controlling interest in PRISM Vision Holdings, a leading provider of ophthalmology and retina management services. The transaction values at approximately $850 million for an 80% stake, while PRISM physicians retain the remaining 20% interest.
The strategic acquisition aims to establish McKesson as a leading platform in retinal and ophthalmology services, enhancing its differentiated value proposition, clinical services, and distribution offerings. The company also announced it will release its fourth quarter and full year fiscal 2025 financial results after market close on May 8, 2025, followed by an earnings conference call at 4:30 PM Eastern Time.
McKesson (NYSE: MCK) ha completato l'acquisizione di una partecipazione di controllo in PRISM Vision Holdings, un fornitore leader di servizi di oftalmologia e gestione della retina. La transazione è valutata a circa 850 milioni di dollari per una partecipazione dell'80%, mentre i medici di PRISM mantengono il restante 20% di interesse.
L'acquisizione strategica mira a stabilire McKesson come una piattaforma leader nei servizi retinici e oftalmologici, migliorando la sua proposta di valore differenziata, i servizi clinici e le offerte di distribuzione. L'azienda ha anche annunciato che rilascerà i risultati finanziari del quarto trimestre e dell'intero anno fiscale 2025 dopo la chiusura del mercato l'8 maggio 2025, seguiti da una conferenza telefonica sugli utili alle 16:30 ora orientale.
McKesson (NYSE: MCK) ha completado su adquisición de una participación de control en PRISM Vision Holdings, un proveedor líder de servicios de oftalmología y gestión de retina. La transacción está valorada en aproximadamente 850 millones de dólares por una participación del 80%, mientras que los médicos de PRISM retienen el 20% restante de interés.
La adquisición estratégica tiene como objetivo establecer a McKesson como una plataforma líder en servicios de retina y oftalmología, mejorando su propuesta de valor diferenciada, los servicios clínicos y las ofertas de distribución. La compañía también anunció que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2025 después del cierre del mercado el 8 de mayo de 2025, seguido de una llamada de conferencia sobre ganancias a las 4:30 PM, hora del Este.
맥케슨 (NYSE: MCK)은 프리즘 비전 홀딩스의 지배 지분 인수를 완료했습니다. 프리즘 비전 홀딩스는 안과 및 망막 관리 서비스의 선도적인 제공업체입니다. 이번 거래는 80% 지분에 대해 약 8억 5천만 달러로 평가되며, 프리즘 의사들은 나머지 20%의 지분을 유지합니다.
이번 전략적 인수는 맥케슨을 망막 및 안과 서비스의 선도적인 플랫폼으로 자리매김하기 위한 것으로, 차별화된 가치 제안, 임상 서비스 및 유통 제공을 강화하는 데 목적이 있습니다. 또한 회사는 2025 회계연도 4분기 및 전체 연도 재무 결과를 2025년 5월 8일 시장 마감 후 발표할 예정이며, 동부 표준시 기준 오후 4시 30분에 실적 컨퍼런스 콜이 이어질 것입니다.
McKesson (NYSE: MCK) a terminé l'acquisition d'une participation de contrôle dans PRISM Vision Holdings, un fournisseur leader de services d'ophtalmologie et de gestion de la rétine. La transaction est évaluée à environ 850 millions de dollars pour une participation de 80 %, tandis que les médecins de PRISM conservent les 20 % restants.
Cette acquisition stratégique vise à établir McKesson comme une plateforme leader dans les services de rétine et d'ophtalmologie, en améliorant sa proposition de valeur différenciée, ses services cliniques et ses offres de distribution. L'entreprise a également annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année fiscale 2025 après la fermeture du marché le 8 mai 2025, suivie d'une conférence téléphonique sur les résultats à 16h30, heure de l'Est.
McKesson (NYSE: MCK) hat den Erwerb einer Mehrheitsbeteiligung an PRISM Vision Holdings, einem führenden Anbieter von Augenheilkunde- und Netzhautmanagementdiensten, abgeschlossen. Die Transaktion wird auf etwa 850 Millionen Dollar für einen Anteil von 80 % bewertet, während die Ärzte von PRISM die verbleibenden 20 % behalten.
Die strategische Akquisition zielt darauf ab, McKesson als führende Plattform im Bereich der Netzhaut- und Augenheilkundevermittlung zu etablieren und dessen differenziertes Wertangebot, klinische Dienstleistungen und Vertriebsangebote zu verbessern. Das Unternehmen gab außerdem bekannt, dass es seine Finanzzahlen für das vierte Quartal und das gesamte Geschäftsjahr 2025 nach Börsenschluss am 8. Mai 2025 veröffentlichen wird, gefolgt von einer Telefonkonferenz zu den Ergebnissen um 16:30 Uhr Eastern Time.
- Acquired 80% controlling stake in PRISM Vision Holdings for $850 million
- Strategic expansion into ophthalmology and retina management services market
- Enhancement of clinical services and distribution offerings portfolio
- Significant capital outlay of $850 million for acquisition
Announces fourth quarter and full year fiscal 2025 earnings release date
McKesson acquired an approximate
Additionally, McKesson will release its fourth quarter and full year fiscal 2025 financial results after market close on Thursday, May 8, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
The live webcast will be available on McKesson’s Investor Relations website at investor.mckesson.com, along with the company’s earnings release, financial tables and slide presentation.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
Cautionary Statement
Except for historical information, statements in this press release regarding McKesson’s acquisition and related arrangements constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read the important risk factors described in the company’s most recent Form 10-K filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: we may not achieve expected outcomes from the transaction; we might be adversely impacted by delays or other difficulties; we from time to time record significant charges from impairment to goodwill, intangibles and other assets or investments; we might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events, economic events and other catastrophic events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401323966/en/
Investors
Investors@McKesson.com
Media Relations
MediaRelations@McKesson.com
Source: McKesson Corporation
FAQ
How much did McKesson (MCK) pay for PRISM Vision Holdings?
What percentage of PRISM Vision Holdings will physicians retain after McKesson's acquisition?
What is the strategic benefit of McKesson's PRISM Vision acquisition?
When will McKesson (MCK) release its Q4 and FY2025 earnings?
